BioGend Therapeutics Co., Ltd. (TPEX: 6733)
Taiwan
· Delayed Price · Currency is TWD 36.30
-0.10 (-0.27%)
Nov 22, 2024, 1:30 PM CST
BioGend Therapeutics Market Cap
BioGend Therapeutics has a market cap or net worth of 4.51 billion as of November 22, 2024. Its market cap has increased by 12.42% in one year.
Market Cap
4.51B
Enterprise Value
3.89B
Revenue
156.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.30
Market Cap Chart
Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.51B, an increase of 66.18%. That is a compound annual growth rate of 9.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 4.52B | -3.92% |
| Dec 29, 2023 | 4.71B | 109.50% |
| Dec 30, 2022 | 2.25B | -18.50% |
| Dec 30, 2021 | 2.76B | -22.86% |
| Dec 31, 2020 | 3.57B | 46.27% |
| Dec 31, 2019 | 2.44B | -9.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition